Daily feed · SEC Form 4 filings
Insider buying in low-priced stocks — Jul 27, 2018
Open-market purchases where the filing’s own weighted average price is under $5. Price comes from the Form 4 itself, not a market quote.
| Trade | Reported (ET) | Company | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 19, 2018 PForm 4 → | Jul 26, 4:50 pm EDT | Provention Bio, Inc.PRVB | Peter A Appel10% Owner | 750,000 | $4.00 | $3,000,000 | 1,950,000 | +62.5% | plan? late |
| Jul 11, 2018 PForm 4 → | Jul 27, 3:07 pm EDT | GB SCIENCES INCGBLX | John C PossChief Executive Officer, Director | 99,964 | $0.4058 | $40,569 | 225,000 | +79.9% | plan? late |
| Jul 25, 2018 PForm 4 → | Jul 26, 9:38 pm EDT | REALNETWORKS INCRNWK | Robert GlaserChairman and CEO, Director, 10% Owner | 5,600 | $3.50 | $19,576 | 13,186,903 | +0.04% | plan? |
| Jul 25, 2018 PForm 4 → | Jul 27, 6:52 am EDT | HG Holdings, Inc.STLY | Matthew HultquistDirector | 31,000 | $0.59 | $18,290 | 162,460 | +23.6% | plan? |
| Jul 27, 2018 PForm 4 → | Jul 27, 9:31 am EDT | HEMISPHERX BIOPHARMA INCHEB | Thomas K. EquelsExec. Vice Chairman/CEO/Pres., Director | 34,483 | $0.29 | $10,000 | 672,306 | +5.41% | plan? |
| Jul 19, 2018 PForm 4 → | Jul 26, 8:22 pm EDT | ENDONOVO THERAPEUTICS, INC.ENDV | Michael Scott MannPresident, 10% Owner | 8,200 | $0.0345 | $283 | 25,208,498 | +0.03% | plan? late |
A trading day runs to 4:00 pm ET; filings accepted later appear on the next trading day. Rows aggregate a filing’s matching transaction lines — see the methodology for the exact roll-up rules.